Market Inclusions The report includes global and regional market size estimates in value terms, with a forecast period from 2026 to 2036
These drugs have achieved remarkable weight loss and multiple cardiometabolic benefits, including improvements in glycemic control, lipid profiles, blood pressure, inflammation, and hepatic steatosis
For weight management, NICE Technology Appraisal TA875 (semaglutide 2.4 mg) and TA664 (liraglutide 3 mg) stipulate that treatment must be initiated and monitored by specialist weight management services, with specific eligibility criteria and a maximum treatment duration of 2 years
This creates smaller individual GH pulses that may be more tolerable
The second body is cell culture: fibroblasts, keratinocytes and to a lesser extent endothelial and neural cell models, with proliferation, migration, matrix protein output and enzyme activity as readouts